2025-01-13 UNIGRID and Sodion Energy Pte. Ltd HaiPress

SINGAPORE,Jan. 13,2025 -- Sodion Energy,a leading provider of sodium-ion batteries for e-mobility and integrated energy storage solutions in Southeast Asia,has secured a landmark agreement for an initial 10 MWh supply of advanced sodium-ion batteries developed by UNIGRID Inc.,a California-based innovator in sodium-ion battery technology.
This collaboration strengthens Sodion Energy's ability to address the region's rising demand for affordable,eco-friendly,and high-performance battery solutions across mobility and energy storage sectors.
"Our collaboration with UNIGRID is a game-changer," said Dr. CC Hang,Chairman of Sodion Energy. "These next-generation sodium-ion batteries will allow us to tackle key markets,starting with lead-acid battery replacements in e-mobility and extending into large-scale renewable energy projects and grid stabilization initiatives."
Sodium-ion batteries offer distinct advantages,including cost-efficiency,enhanced safety,and the use of abundant raw materials,making them a sustainable choice for energy storage. With fast-charging capabilities and intrinsic non-flammability,they are exceptionally suited to Southeast Asia's tropical climate and rapidly growing energy needs.
With a strategic focus on advanced battery technologies,Sodion Energy is poised to play a key role in driving Southeast Asia's transition to cleaner,safer,and more sustainable energy solutions.
Website: https://sodione.com
Follow us on LinkedIn:Sodion Energy
About Sodion Energy
Headquartered in Singapore,Sodion Energy is an applications engineering leader driving the commercialization of Sodium-ion batteries across Southeast Asia. SE's sodium-ion pack solutions are tailored to meet the diverse needs of industries such as mobility and energy storage,contributing to a more sustainable future.
Cangxi County Holds 2026 New Year's Cultural Performance for the Public
The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange
Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement
©copyright 2009-2020 Singapore Info Map